Stock Research for ATNM

ATNM

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ATNM Stock Chart & Research Data

The ATNM chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ATNM chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ATNM Due diligence Resources & Stock Charts

The ATNM stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ATNM Detailed Price Forecast - CNN Money CNN View ATNM Detailed Summary - Google Finance
Yahoo View ATNM Detailed Summary - Yahoo! Finance Zacks View ATNM Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ATNM Trends & Analysis - Trade-Ideas Barrons View ATNM Major Holders - Barrons
NASDAQ View ATNM Call Transcripts - NASDAQ Seeking View ATNM Breaking News & Analysis - Seeking Alpha
Spotlight View ATNM Annual Report - CompanySpotlight.com OTC Report View ATNM OTC Short Report - OTCShortReport.com
TradeKing View ATNM Fundamentals - TradeKing Charts View ATNM SEC Filings - Bar Chart
WSJ View Historical Prices for ATNM - The WSJ Morningstar View Performance/Total Return for ATNM - Morningstar
MarketWatch View the Analyst Estimates for ATNM - MarketWatch CNBC View the Earnings History for ATNM - CNBC
StockMarketWatch View the ATNM Earnings - StockMarketWatch MacroAxis View ATNM Buy or Sell Recommendations - MacroAxis
Bullish View the ATNM Bullish Patterns - American Bulls Short Pains View ATNM Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ATNM Stock Mentions - StockTwits PennyStocks View ATNM Stock Mentions - PennyStockTweets
Twitter View ATNM Stock Mentions - Twitter Invest Hub View ATNM Investment Forum News - Investor Hub
Yahoo View ATNM Stock Mentions - Yahoo! Message Board Seeking Alpha View ATNM Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ATNM - SECform4.com Insider Cow View Insider Transactions for ATNM - Insider Cow
CNBC View ATNM Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ATNM - OTC Markets
Yahoo View Insider Transactions for ATNM - Yahoo! Finance NASDAQ View Institutional Holdings for ATNM - NASDAQ


Stock Charts

FinViz View ATNM Stock Insight & Charts - FinViz.com StockCharts View ATNM Investment Charts - StockCharts.com
BarChart View ATNM Stock Overview & Charts - BarChart Trading View View ATNM User Generated Charts - Trading View




Latest Financial News for ATNM


Actinium Appoints Accomplished FDA and Industry Professional Mamata Gokhale, Ph.D., RAC as Vice President, Global Head of Regulatory Affairs
Posted on Tuesday March 19, 2019

NEW YORK, March 19, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), announced today the appointment of Mamata Gokhale, Ph.D., RAC as Vice President, Global Head of Regulatory Affairs. In this role, Dr. Gokhale will be responsible for developing and implementing a comprehensive clinical regulatory strategy across Actinium's portfolio of ARC or Antibody Radiation-Conjugate product candidates for targeted conditioning.


Actinium Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Highlights
Posted on Tuesday March 19, 2019

NEW YORK, March 19, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) reported its financial results for the fourth quarter and year ended December 31, 2018 as well as provided corporate and operational updates on clinical trials, research and development, recent hires, and intellectual property. Iomab-B is an ARC or Antibody Radiation-Conjugate that targets CD45, an antigen expressed on leukemia, lymphoma and immune cells, and delivers Iodine-131 that kills targeted cells via linear energy transfer.


Actinium Provides Comprehensive Patent Portfolio Update Including New IP Filings
Posted on Friday March 15, 2019

NEW YORK, March 15, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), announced today that the rejuvenation of R&D activity has bolstered its patent portfolio to a total of 111 issued and pending patents in the U.S. and internationally, which is up from the 75 reported previously.


Actinium Pharmaceuticals to Present at the Oppenheimer & Co. 29th Annual Healthcare Conference
Posted on Friday March 15, 2019

- Presentation scheduled for 1:35 pm ET on Wednesday, March 20th NEW YORK , March 15, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.  (NYSE American: ATNM) ("Actinium" or "the Company") ...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.